186 related articles for article (PubMed ID: 34216749)
1. Nomogram to Predict Cancer Specific Survival in Patients with Pathological Stage IA Non-small Cell Lung Cancer.
Cai JS; Dou XM; Li JB; Yang MZ; Xie CL; Hou X; Yang HX
Semin Thorac Cardiovasc Surg; 2022; 34(3):1040-1048. PubMed ID: 34216749
[TBL] [Abstract][Full Text] [Related]
2. Prognostic nomograms and risk-stratifying systems for predicting survival in patients with resected pT2-4aN0M0 esophageal carcinoma.
Dou XM; Zhang N; Fang YY; Zhang BH; Liao JJ; Cai JS; Li JB
J Thorac Dis; 2021 Apr; 13(4):2363-2377. PubMed ID: 34012585
[TBL] [Abstract][Full Text] [Related]
3. Stratification of Patients With Stage IB NSCLC Based on the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging Manual.
Wu LL; Liu X; Jiang WM; Huang W; Lin P; Long H; Zhang LJ; Ma GW
Front Oncol; 2020; 10():571. PubMed ID: 32373536
[No Abstract] [Full Text] [Related]
4. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
[No Abstract] [Full Text] [Related]
5. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
Li H; Wang Z; Yang F; Wang J
J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
[TBL] [Abstract][Full Text] [Related]
6. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790
[TBL] [Abstract][Full Text] [Related]
7. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.
Huang X; Hu P; Yan F; Zhang J
Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800
[No Abstract] [Full Text] [Related]
8. Survival Nomogram for Stage IB Non-Small-Cell Lung Cancer Patients, Based on the SEER Database and an External Validation Cohort.
Zuo Z; Zhang G; Song P; Yang J; Li S; Zhong Z; Tan Q; Wang L; Xue Q; Gao S; Sun N; He J
Ann Surg Oncol; 2021 Jul; 28(7):3941-3950. PubMed ID: 33249521
[TBL] [Abstract][Full Text] [Related]
9. A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer.
Zeng Y; Mayne N; Yang CJ; D'Amico TA; Ng CSH; Liu CC; Petersen RH; Rocco G; Brunelli A; Liu J; Liu Y; Huang W; He J; Wang W; Jiang L; Cui F; Wang W; Liang W; He J;
Ann Surg Oncol; 2019 Jul; 26(7):2053-2062. PubMed ID: 30900105
[TBL] [Abstract][Full Text] [Related]
10. A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database.
Jia B; Zheng Q; Wang J; Sun H; Zhao J; Wu M; An T; Wang Y; Zhuo M; Li J; Yang X; Zhong J; Chen H; Chi Y; Zhai X; Wang Z
BMC Cancer; 2020 Jul; 20(1):666. PubMed ID: 32680464
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
[TBL] [Abstract][Full Text] [Related]
12. Significance of metastatic lymph nodes ratio in overall survival for patients with resected nonsmall cell lung cancer: a retrospective cohort study.
Lin X; Yao J; Huang B; Chen T; Xie L; Huang R
Eur J Cancer Prev; 2024 Jul; 33(4):376-385. PubMed ID: 38842873
[TBL] [Abstract][Full Text] [Related]
13. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.
Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C
Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033
[TBL] [Abstract][Full Text] [Related]
14. The nomogram for the prediction of overall survival after surgery in patients in early-stage NSCLC based on SEER database and external validation cohort.
Zhang H; Zeng J; Li X; Zhang B; Wang H; Tang Q; Zhang Y; Bao S; Zu L; Xu X; Xu S; Song Z
Cancer Med; 2024 Jan; 13(1):e6751. PubMed ID: 38148585
[TBL] [Abstract][Full Text] [Related]
15. Development and External Validation of a Nomogram for Predicting Survival in Patients With Stage IA Non-small Cell Lung Cancer ≤2 cm Undergoing Sublobectomy.
Wo Y; Yang H; Zhang Y; Wo J
Front Oncol; 2019; 9():1385. PubMed ID: 31921643
[No Abstract] [Full Text] [Related]
16. A risk classification system predicting the cancer-specific survival for postoperative stage IB non-small-cell lung cancer patients without lymphovascular and visceral pleural invasion.
Tu Z; Li C; Tian T; Chen Q
Lung Cancer; 2021 Nov; 161():114-121. PubMed ID: 34583219
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: a study based on the SEER database and a Chinese cohort.
Zhou L; Zhang Y; Chen W; Niu N; Zhao J; Qi W; Xu Y
BMC Cancer; 2022 Sep; 22(1):980. PubMed ID: 36104656
[TBL] [Abstract][Full Text] [Related]
18. Nomogram Predicting the Prognosis of Patients with Surgically Resected Stage IA Non-small Cell Lung Cancer.
Deng XF; Dai Y; Liu XQ; Qi HZ; Zhou D; Zheng H; Li J; Liu QX
Indian J Surg Oncol; 2023 Jun; 14(2):376-386. PubMed ID: 37324285
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a nomogram to predict cancer-specific survival of uveal melanoma.
Zeng Q; Yao Y; Zhao M
BMC Ophthalmol; 2021 May; 21(1):230. PubMed ID: 34030647
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
